RecruitingPhase 2Phase 3NCT05504265

Perioperative Analgesia Modes in Minimally Invasive Esophagectomy

Comparison of Efficacy and Safety of Different Analgesic Modes in Minimally Invasive Esophagectomy for Esophageal Cancer


Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Enrollment

102 participants

Start Date

Oct 10, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study was designed to compare analgesic efficacy and safety of different perioperative analgesic modes in minimally invasive esophagectomy for esophageal cancer.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing different methods of pain control after minimally invasive surgery to remove the esophagus (esophagectomy) — a major operation for esophageal cancer. Researchers want to find out which approach provides the best pain relief with the fewest side effects. **You may be eligible if...** - You are between 18 and 75 years old - You are scheduled for minimally invasive esophagectomy (laparoscopic, thoracoscopic, or robotic) - You have provided informed consent **You may NOT be eligible if...** - You have had cholecystitis (gallbladder inflammation) or kidney stones in the past 3 months - You have had a stroke, heart attack, or peripheral artery disease - You have lung disease, severe heart disease, or already have a chest drain - You drink heavily (more than defined safe limits) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPreemptive flurbiprofen axetil

50mg once,30min before induction anesthesia

DRUGPostoperative flurbiprofen axetil

50mg bid

DEVICEPatient-controlled analgesia pump

Sufentanil 2.5 μg/kg+ondansetron 8mg, prepared to 100ml normal saline; background dose: 2 ml/h, single press analgesic pump injection volume: 0.5 ml, locking time: 15 min.


Locations(1)

Cancer Hospital Chinese Academy of Medical Sciences

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05504265


Related Trials